These molecular disruptions result in neurodegenerative phenotypes, including SPAX5 (spastic ataxia 5), SCA28 (spinocerebellar ataxia 28), and OPA12 (optic atrophy 12). The gene discussed is AFG3L2; the disease is spastic ataxia 5.